NCT06041126Completed
The Effect of Clinical Parameters on Muscle Oxygenation in Patients With COPD
The Effect of Disease Severity and Respiratory Functions on Muscle Oxygenation in Stable COPD Patients
Source: ClinicalTrials.gov · Last updated 13 Mar 2025
Brief summary (registry, in English)
The aim of this study is to examine the peripheral muscle oxygenation of patients with Chronic Obstructive Pulmonary Disease at rest, during submaximal exercise and recovery, and to examine the effects of disease severity and respiratory functions on peripheral muscle oxygenations. In this study, the effect of disease severity and respiratory problems on peripheral muscle metabolism of patients with COPD will be explained.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 41 (actual)
- First submitted
- 27 Apr 2023
- Start date
- 24 Apr 2023
- Primary completion date
- 23 Jun 2024
- Lead sponsor
- Bandırma Onyedi Eylül University
- Diseases
- COPD
- NCT number
- NCT06041126
What you commit to
- Study type: Observational
- Participants enrolled: 41
- From 24 Apr 2023 to the primary completion date, 23 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Arthritis causing weakness in the lower extremity, neurological disease, deep vein thrombosis, peripheral arterial disease, muscle weakness, fracture etc. patients with the condition
- Common diseases such as malignancy, pulmonary embolism, vasculitis, collagen tissue diseases, interstitial fibrosis, severe pneumonia patients with parenchymal destruction
Other
- Patients who do not want to participate in the study
- Patients with severe dyspnea and hemodynamic instability who cannot perform the 6 Minute Walk Test
Who the study is looking for
- Being diagnosed with COPD (according to GOLD Staging: GOLD 1, GOLD 2, GOLD 3, GOLD 4)
- Being between the ages of 40-80
- Body Mass Index \<35
- Not having an acute exacerbation in the last 3 months
Age in the registry: 40 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bandırma Onyedi Eylül University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation Coordinator of this site? Confirm its status | Balıkesir | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.